Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring

Ji-Guang Wang¹, Yan Li¹, Yook-Chin Chia^{2

3}, Hao-Min Cheng^{4

5

6

7}, Huynh Van Minh⁸, Saulat Siddique⁹, Guru Prasad Sogunuru^{10

11}, Jam Chin Tay¹², Boon Wee Teo¹³, Kelvin Tsoi¹⁴, Yuda Turana¹⁵, Tzung-Dau Wang^{16

17}, Yu-Qing Zhang¹⁸, Kazuomi Kario¹⁹; Hypertension Cardiovascular Outcome Prevention, Evidence (HOPE) Asia Network

Affiliations

¹ Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, Department of Hypertension, Ruijin Hospital, The Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Shanghai, China.
² Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
³ Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.
⁴ Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan.
⁵ Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
⁶ Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
⁷ Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.
⁸ Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue City, Vietnam.
⁹ Punjab Medical Center, Lahore, Pakistan.
¹⁰ MIOT International Hospital, Chennai, India.
¹¹ College of Medical Sciences, Kathmandu University, Bharatpur, Nepal.
¹² Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
¹³ Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore.
¹⁴ JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
¹⁵ School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
¹⁶ Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
¹⁷ Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
¹⁸ Divisions of Hypertension and Heart Failure, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
¹⁹ Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

PMID: 33484617
PMCID: PMC8029526
DOI: 10.1111/jch.14194

Review

Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring

Ji-Guang Wang et al. J Clin Hypertens (Greenwich). 2021 Mar.

. 2021 Mar;23(3):435-439.

doi: 10.1111/jch.14194. Epub 2021 Jan 23.

Authors

Affiliations

¹ Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, Department of Hypertension, Ruijin Hospital, The Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Shanghai, China.
² Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
³ Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.
⁴ Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan.
⁵ Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
⁶ Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
⁷ Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.
⁸ Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue City, Vietnam.
⁹ Punjab Medical Center, Lahore, Pakistan.
¹⁰ MIOT International Hospital, Chennai, India.
¹¹ College of Medical Sciences, Kathmandu University, Bharatpur, Nepal.
¹² Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
¹³ Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore.
¹⁴ JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
¹⁵ School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
¹⁶ Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
¹⁷ Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
¹⁸ Divisions of Hypertension and Heart Failure, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
¹⁹ Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

PMID: 33484617
PMCID: PMC8029526
DOI: 10.1111/jch.14194

Abstract

The prevalence of hypertension is high and still increasing in almost all communities regardless of high, middle, or low income. The control rate remains low in most countries. Telemedicine offers possibilities to improve blood pressure control. The past two decades witnessed the fast evolving telecommunication from telephone transmission to smart mobile phone technology for telemedicine. There is some evidence from randomized controlled trials that telemonitoring improves blood pressure control. However, it requires co-interventions. The emerging new technology may offer even more possibilities in telemonitoring and co-interventions, for instance, an interactive platform between patients and health professionals for the management of hypertension. Telemedicine might ultimately change the situation of the unsatisfactory management of hypertension in many communities. It helps fully utilize antihypertensive treatment, the most effective cardiovascular prevention, to achieve the goal of ending atherosclerosis and arteriosclerosis in humans.

Keywords: hypertension; technology; telemedicine; telemonitoring.

PubMed Disclaimer

Conflict of interest statement

JG Wang has received consulting and lecture fees from AstraZeneca, Novartis, Omron, Servier, and Takeda. YC Chia has received speaker honorarium and sponsorship to attend conferences and seminars from Boehringer Ingelheim, Omron, Pfizer, Servier, and Xepa‐Sol and investigator‐initiated research grants from Pfizer and Omron. HM Cheng has received speaker honorarium and sponsorship to attend conferences and continued medical education (CME) seminars from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi‐Sankyo, Eli Lilly, Menarini, Novartis, Pfizer, Sanofi, Servier, and Takeda, and served as an advisor or consultant for ApoDx Technology, Inc S Siddique has received honoraria from Bayer, ICI, Novartis, Pfizer, and Servier; and travel, accommodation, and conference registration support from Atco Pharmaceutical, Hilton Pharma, Highnoon Laboratories, Horizon Pharma, and ICI. K Kario has received research grants from Omron Healthcare, Fukuda Denshi, A&D, and Pfizer Japan, and honoraria from Omron Healthcare. All other authors report no potential conflicts of interest in relation to this review paper.

References

1. Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012‐2015. Circulation. 2018;137:2344‐2356. - PubMed
1. Li LM, Rao KQ, Kong LZ, et al. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol. 2005;26:478‐484 (Chinese). - PubMed
1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13‐115. - PubMed
1. Rabi DM, McBrien KA, Sapir‐Pichhadze R, et al. Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020;36(5):596‐624. - PubMed
1. Wang JG, Liu L. Global impact of 2017 American College of Cardiology/American Heart Association hypertension guidelines: a perspective from China. Circulation. 2018;137(6):546‐548. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring

Affiliations

Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous